Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program

被引：0
|
作者：
Dufresne, A. [1 ]
Huillard, O. [2 ]
Dalban, C. [3 ]
Geier, M. [4 ]
Wassermann, J. [5 ,6 ]
Zanetta, S. [7 ]
Cabourg, M. [8 ]
Catargi, B. [9 ]
El Kouri, C. [10 ]
Hrab, I. [11 ]
Laramas, M. [12 ]
Moreira, A. [13 ]
Saada, E. B. [14 ]
Tournigand, C. [15 ]
Valentin, T. [16 ]
Vauleon, E. [17 ]
Mayet, R.
Perol, D. [18 ]
Blay, J-Y. [19 ]
机构：
[1] Ctr Leon Berard, Med Oncol, Lyon, France
[2] Hop Cochin, AP HP, Med Oncol, Paris, France
[3] Ctr Leon Berard, Clin Res Dept, Lyon, France
[4] Univ Hosp Brest, CHRU Morvan, Med Oncol, Brest, France
[5] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Thyroid & Endocrine Tumors,GRC Tumeurs Thyro, Paris, France
[6] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Med Oncol Dept,GRC Tumeurs Thyroidienned,IUC,GRC, Paris, France
[7] Ctr Georges Francois Leclerc, Med Oncol, Dijon, France
[8] Hosp Ctr Intercommunal Elbeuf Louviers Val De Reu, Med Oncol, St Aubin, France
[9] Hop St Andre, CHU Bordeaux, Endocrinol, Bordeaux, France
[10] Ctr Catherine Sienne, Med Oncol, Nantes, France
[11] Ctr Francois Baclesse, Med Oncol, Caen, France
[12] CHU Grenoble Alpes Site Nord, Med Oncol, La Tronche, France
[13] CHU Amiens, Med Oncol, Amiens, France
[14] Ctr Antoine Lacassagne, Med Oncol, Nice, France
[15] Ctr Hosp Univ Henri Mondor, AP HP, Med Oncol, Creteil, France
[16] Inst Univ Canc Toulouse Oncopole, Med Oncol, Toulouse, France
[17] Ctr Eugene Marquis, Med Oncol, Rennes, France
[18] Ctr Leon Berard, Clin Res Dept, Lyon, France
[19] Ctr Leon Berard, Med Dept, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
465P
引用
收藏
页码：S753 / S753
页数：1
相关论文
共 50 条
  • [31] Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP)
    Faehling, M.
    Schumann, C.
    Christopoulos, P.
    Hoffknecht, P.
    Alt, J.
    Horn, M.
    Eisenmann, S.
    Schlenska-Lange, A.
    Aries, S. P.
    Sackmann, S.
    Schuett, P.
    Steger, F.
    Christoph, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S806 - S807
  • [32] Historical data in real life from patients treated by vinflunine for an advanced or metastatic urothelial carcinoma: Results of the CURVE study
    Medioni, J.
    Guillot, A.
    Spaeth, D.
    Di Palma, M.
    Theodore, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S646 - S647
  • [33] Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study
    Shitara, Kohei
    Yamaguchi, Kensei
    Muro, Kei
    Yasui, Hisateru
    Sakai, Daisuke
    Oshima, Takashi
    Fujimura, Masahiro
    Sato, Yuta
    Yamazaki, Shunsuke
    Wakabayashi, Tatsuya
    Sugihara, Masahiro
    Kamio, Takahiro
    Shoji, Hirokazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (01) : 27 - 35
  • [34] Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study
    Kohei Shitara
    Kensei Yamaguchi
    Kei Muro
    Hisateru Yasui
    Daisuke Sakai
    Takashi Oshima
    Masahiro Fujimura
    Yuta Sato
    Shunsuke Yamazaki
    Tatsuya Wakabayashi
    Masahiro Sugihara
    Takahiro Kamio
    Hirokazu Shoji
    International Journal of Clinical Oncology, 2024, 29 : 27 - 35
  • [35] Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
    Wang, Han-Min
    Zhang, Chan-Yuan
    Peng, Kai-Cheng
    Chen, Ze-Xin
    Su, Jun-Wei
    Li, Yu-Fa
    Li, Wen-Feng
    Gao, Qing-Yun
    Zhang, Shi-Ling
    Chen, Yu-Qing
    Zhou, Qing
    Xu, Cong
    Xu, Chong-Rui
    Wang, Zhen
    Su, Jian
    Yan, Hong-Hong
    Zhang, Xu-Chao
    Chen, Hua-Jun
    Wu, Yi-Long
    Yang, Jin-Ji
    CELL REPORTS MEDICINE, 2023, 4 (02)
  • [36] Combination Therapy of Lapatinib and Capecitabine for ErbB2-Positive Metastatic or Locally Advanced Breast Cancer: Results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe
    Greil, Richard
    Borstnar, Simona
    Petrakova, Katarina
    Marcou, Yiola
    Pikiel, Joanna
    Wojtukiewicz, Marek Z.
    Koza, Ivan
    Steger, Guenther G.
    Linn, Meinolf
    Das Gupta, Ash
    Cwiertka, Karel
    ONKOLOGIE, 2011, 34 (05): : 233 - 238
  • [37] EV-202: A phase II study of enfortumab vedotin in patients with select previously treated locally advanced or metastatic solid tumors.
    Bruce, Justine Yang
    Pusztai, Lajos
    Braiteh, Fadi S.
    Gorla, Seema Rao
    Wu, Chunzhang
    Baranda, Joaquina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Osimertinib in EGFR T790M positive advanced NSCLC (aNSCLC) - real-life data from the French temporary authorization for use (ATU) program
    Planchard, D.
    Perol, M.
    Quantin, X.
    Cortot, A.
    Cadranel, J.
    Schott, R.
    Dansin, E.
    Fraboulet, G.
    Moro-Sibilot, D.
    Soria, J-C.
    Mazieres, J.
    Le Moulec, S.
    Coudurier, M.
    Pichon, E.
    Licour, M.
    Maribas, D.
    Gourion, A.
    Radu, N.
    Varoqueaux, N.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience
    De Felice, Francesca
    Siniscalchi, Benedetta
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Musio, Daniela
    Tombolini, Vincenzo
    ANTICANCER RESEARCH, 2019, 39 (12) : 6957 - 6963
  • [40] Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
    Basoglu, Tugba
    Sakin, Abdullah
    Erol, Cihan
    Ozden, Ercan
    cabuk, Devrim
    Cilbir, Ebru
    Tataroglu ozyukseler, Deniz
    Ayhan, Murat
    Sendur, Mehmet Ali
    Dogan, Mutlu
    Oksuzoglu, Berna
    Eryilmaz, Melek Karakurt
    Er, Ozlem
    Tasci, Elif Senocak
    Ozyurt, Neslihan
    Dulgar, Ozgecan
    Ozen, Mirac
    Hacibekiroglu, Ilhan
    Oner, Irem
    Bekmez, Esma Turkmen
    Cagri Yildirim, Hasan
    Yalcin, Suayib
    Paydas, Semra
    Yekeduz, Emre
    Aksoy, Asude
    Ozcelik, Melike
    Oyman, Abdilkerim
    Almuradova, Elvina
    Karabulut, Bulent
    Demir, Nazan
    Dincer, Murat
    Ozdemir, Nuriye
    Erdem, Dilek
    Ak, Naziye
    Inal, Ali
    Salim, Derya Kivrak
    Deniz, Gulhan Ipek
    Sakalar, Teoman
    Gulmez, Ahmet
    Kacan, Turgut
    Ozdemir, Ozlem
    Alan, Ozkan
    Unal, Caglar
    Karakas, Yusuf
    Turhal, Serdar
    Yumuk, Perran Fulden
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (02) : 142 - 149
12345